Proactive Investors
06 Jul 2026, 12:43 UTC · 3h ago
AtaiBeckley completes dosing in Phase 2b depression trial, expects topline data in Q4
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Proactive Investors
06 Jul 2026, 12:43 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
AtaiBeckley Inc. expects to release topline results from its Phase 2b Elumina clinical trial for VLS-01 in the fourth quarter of 2026. — Topline results are primary catalysts for biotech stocks, though the current announcement is only a timing update, not a data release.
+0.40AtaiBeckley has completed dosing the final patient in the Phase 2b Elumina trial for the treatment of treatment-resistant depression. — Completing dosing is a positive operational milestone that confirms the trial is on track, reducing execution risk.
+0.20The company intends to advance VLS-01 into Phase 3 for major depressive disorder, contingent upon supportive Phase 2 results. — Outlining a path to Phase 3 shows strategic ambition but depends entirely on future data success.
+0.10Which stocks this story touches
Continue reading
6 related stories
Top 1 mover · tap to explore
The company reached a clinical operations milestone by completing dosing for its Phase 2b trial of VLS-01.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Proactive Investors
7h ago
